Acellular dermal matrix (ADM) has gained extensive popularity across reconstructive and plastic surgery over recent decades. Surgeons value this tissue-engineered biological scaffold because it promotes revascularization, cellular repopulation, and structural tissue support. Consequently, researchers have recently explored the utility of ADM in spine surgery. Orthopedic surgeons and neurosurgeons often face challenging clinical scenarios, including persistent cerebrospinal fluid leaks, extensive durotomies, and post-discectomy scarring. Biological scaffolds theoretically offer an optimal alternative to synthetic meshes by reducing foreign body reactions. However, rigorous clinical evidence evaluating these applications has historically remained fragmented. A landmark systematic review published in 2026 synthesized available clinical trials to evaluate whether clinical outcomes support expanding this biomaterial into spinal procedures.

Current Evidence Base for ADM in Spine Surgery

Investigators conducted an exhaustive systematic review following PRISMA 2020 guidelines to aggregate all human clinical evidence. Specifically, researchers queried PubMed, Embase, Cochrane CENTRAL, Web of Science, and Scopus through July 2026. The authors registered their protocol prospectively under PROSPERO and identified ten eligible clinical studies comprising 385 enrolled patients. They stratified clinical evidence a priori into three distinct clinical tiers to preserve analytical rigor. Seven studies provided direct spine surgery evidence involving 172 patients. Meanwhile, two studies covered craniovertebral and neuraxis indications across 13 patients. Finally, one larger series involved 200 patients undergoing predominantly cranial duraplasty. Across this literature, the review identified five primary application categories. These clinical categories included anterior cervical anti-adhesion barriers, posterior dural defect reconstruction, spinal dysraphism wound repair, epidural fibrosis reduction, and complex soft-tissue envelope reinforcement. Therefore, this synthesis provides an essential panoramic view of emerging applications across the entire spinal axis.

Clinical Efficacy and the Anterior Cervical Spine

Surgeons frequently encounter troublesome postoperative dysphagia following anterior cervical discectomy and fusion (ACDF). In theory, placing an interpositional matrix between the anterior instrumentation and the esophagus cushions delicate visceral structures. Among all identified studies, only one study provided comparative clinical data. This study evaluated a propensity score-matched cohort of 108 patients undergoing ACDF. Researchers compared micronized ADM against conventional anti-adhesive gel barriers to measure postoperative swallowing morbidity. Patients in the ADM cohort demonstrated statistically lower Swallowing Impairment Scores at the three-month evaluation (0.26 ± 0.16 versus 0.68 ± 0.27, p = 0.01). Furthermore, this beneficial difference retained statistical significance after rigorous Bonferroni correction. Nevertheless, critical methodological caveats diminish the practical weight of these findings. Specifically, the observed absolute score difference of 0.42 fell below the validated minimal clinically important difference threshold. Additionally, magnetic resonance imaging assessments revealed that objective tissue adhesion scores did not differ between cohorts. Thus, clear clinical superiority remains unproven.

Dural Reconstruction and Posterior Spinal Procedures

Incidental durotomy represents a frequent and frustrating intraoperative complication during spinal decompression and instrumented deformity correction. Traditional repair demands watertight primary suture closure, yet friable dural edges frequently prevent primary apposition. Consequently, surgeons have tested planar sheets of ADM as patch grafts or onlay shields to prevent persistent cerebrospinal fluid fistula formation. In pediatric spinal dysraphism cases, massive myelomeningocele defects frequently lack adequate cutaneous and myofascial layers for primary tension-free coverage. Several surgical series demonstrated that suturing an acellular dermal sheet directly over repaired neural placodes provided a dependable structural stratum. This intervention allowed successful secondary epithelialization without immediate cerebrospinal fluid leakage. Similarly, posterior lumbar studies examined whether ADM barriers could prevent dense post-laminectomy epidural fibrosis. Fibrosis frequently tethers spinal nerve roots and generates recalcitrant radicular pain. While preliminary reports described uncomplicated healing and stable dural closure, nearly all included posterior studies were small, uncontrolled case series or descriptive cohorts. Therefore, uncontrolled study designs preclude definitive efficacy assertions.

Methodological Quality and Risk of Bias Considerations

To appraise evidence quality objectively, the systematic review investigators implemented the ROBINS-I tool alongside Joanna Briggs Institute critical appraisal checklists. Furthermore, they rated overall evidence certainty using the GRADE framework. Unfortunately, methodological quality across available spine literature remains markedly constrained. Because nine out of ten studies lacked comparative control arms, severe selection bias and confounding inherently distort published outcomes. Consequently, the authors determined that certainty under GRADE guidelines was very low across every evaluated outcome. Moreover, reported adverse event rates appeared remarkably low, but surveillance protocols lacked standardized prospective criteria. Without active monitoring protocols, retrospective cohorts consistently underreport low-grade wound infections, seroma accumulation, and graft dislodgement. Therefore, current published data cannot substantiate the definitive safety profile of dermal scaffolds in spinal environments. Spine surgeons must recognize that results observed in cranial dural closure cannot automatically translate into the elevated hydrostatic pressures of the lumbar spine.

Formulation Differences and Future Surgical Directions

Acellular matrices are not biologically uniform products. Rather, processing techniques vary considerably among manufacturers and tissue sources. Some matrices derive from human cadaveric allografts, whereas others originate from porcine or bovine xenografts. Furthermore, processing methods alter cross-linking density, terminal sterilization exposure, and extracellular matrix preservation. Certain formulations exist as lyophilized or hydrated structural sheets, whereas others use micronized, reprocessed flowable matrices. Consequently, biomechanical tensile strength, host immune degradation, and tissue incorporation vary dramatically between commercial products. The systematic review highlighted that clinical findings remain strictly product-specific and indication-specific. Clinicians should not generalize functional outcomes from one proprietary scaffold to alternative biological formulations. Moving forward, spine teams require high-quality prospective randomized controlled trials. These trials must incorporate validated patient-reported outcome measures, standardized imaging criteria, and rigorous cost-effectiveness analyses. Until comparative trials materialize, operating surgeons should approach routine application of these premium biomaterials with measured clinical caution.

Frequently Asked Questions

What is the primary role of ADM in anterior cervical surgery?

Surgeons place acellular dermal matrix anteriorly during cervical fusions to create a protective biological cushion. This barrier separates metallic plates from the adjacent esophagus. Theoretically, the material reduces soft tissue shearing, limits localized fibrotic scarring, and minimizes persistent postoperative dysphagia during early recovery phases.

Does current clinical evidence confirm the safety of ADM in spine surgery?

Current published literature cannot confirm definitive safety. Although studies report infrequent adverse reactions, adverse event monitoring has been largely retrospective and inconsistent. Potential complications such as seroma formation, deep infections, and graft migration require rigorous prospective surveillance before surgeons can establish definitive safety standards.

How strong is the evidence supporting ADM for spinal dural tears?

Evidence supporting spinal dural reconstruction remains very weak. Existing literature consists primarily of retrospective, uncontrolled case series with very low GRADE certainty. While preliminary technical feasibility exists, clinicians lack robust randomized comparative trials demonstrating superiority over conventional autologous fascial grafts, collagen matrices, or synthetic dural sealants.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Always consult a qualified healthcare provider for diagnosis and treatment recommendations. Refer to the latest local and national guidelines for clinical practice.

References

Kim DH et al. Applications of acellular dermal matrix in spine surgery: A systematic review. Neurosurg Rev. 2026 Oct 07. doi: 10.1007/s10143-026-04521-5. PMID: 42842030.

Kim DH, Hur JW, Hong JT. Effect of Reprocessed Micronized Acellular Dermal Matrix on Postoperative Dysphagia After Anterior Cervical Discectomy and Fusion: A Propensity Score-Matched Study. Medicina (Kaunas). 2026 Jun 15;62(6):1163. doi: 10.3390/medicina62061163.

Susarla SM, Mundinger GS, Swanson JW, Ettinger RE, Gruss JS, Hopper RA. Acellular Dermal Matrix as a Definitive Reconstructive Option for Management of a Large Myelomeningocele Defect in the Setting of Severe Lumbar Kyphosis. World Neurosurg. 2019 Sep;129:315-318. doi: 10.1016/j.wneu.2019.06.116.